Download Your Copy of the Agenda
Discover how the 4th Cell Therapy for Autoimmune Disease Summit is helping developers navigate the next phase of growth across autoimmune cell therapy. Download the full agenda to explore the latest clinical and translational case studies and discussions addressing the industry's most pressing scientific, manufacturing, and commercialization challenges.
Whether you're advancing a preclinical program or scaling a later-stage asset, the agenda provides a complete overview of the workshops, presentations, panel discussions, and networking opportunities designed to help you advance your cell therapy development for autoimmune diseases.
Find Out Why These Companies Are Prioritizing Cell Therapies Treating Autoimmune Disease
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
The rapid and remarkable expansion of research in the use of cell therapy to treat autoimmune diseases has revealed the great potential for these novel approaches to transform the lives of patients with these challenging diseases.
University of Pennsylvania
The conference had a great set of attendees from academia, biotech and large pharma. This facilitated progressive and open discussion during talks, panels and roundtables.
Cabaletta Bio
![Novartis[1]](https://cell-therapy-autoimmune-disease.com/wp-content/uploads/sites/286/2026/02/Novartis1.png "Novartis[1]")
It was great to hear different perspectives from leaders within our industry. It provided strategic thinking beyond data perceptions.
Novartis
Beyond my expectation, I could connect a lot of people who have engaged in the field in clinical or pharma, biotech, academia. This was a really important experience to make a strong relationships and network in the field.
ONO Pharmaceutical Co.